absorb.md

About Charles Mosseri Marlio

n/a at n/a

Compiled from 8 entries (8 articles) / updated 1d ago / v1

Charles Mosseri Marlio is an experienced biotech investor and significant shareholder in companies like Nuvectis Pharma and Flamel Technologies (now Avadel), with a notable interest in natural wine as an early supporter of related publications. His activities center on strategic investments in the biotech and pharmaceutical sectors, demonstrating confidence in growth prospects through substantial stock purchases and holdings. Limited public content suggests a blend of financial acumen in healthcare innovation and cultural engagement in food and agriculture-related topics like natural wine.

Investment in Biotech and Pharmaceuticals

Charles Mosseri Marlio is a prominent investor in the biotech sector, particularly noted for his stakes in Nuvectis Pharma (NASDAQ: NVCT). He filed a Form 4 on June 20 revealing his significant shareholder status,[1] and an SC 13G statement on February 15, 2022, disclosing 9.95% beneficial ownership.[4] Recent transactions include purchasing $247k in Nuvectis stock,[8] contributing to market cap boosts that benefited insiders, such as US$18m and US$22m increases where individual investors holding 44% profited alongside insiders.[6][7]

He is also associated with Flamel Technologies (now Avadel Pharmaceuticals), with contact details listed as cmarlio@gmail.com and cmarlio@avadel.com,[2] and described as a key figure in the hedge fund world connected to the company.[5]

Interest in Natural Wine and Food Culture

Mosseri Marlio has been identified as an early supporter of natural wine literature, with a preference for using both surnames 'Mosseri Marlio' as noted in errata for 'THE WORLD OF NATURAL WINE'.[3] This aligns with the designated topic of Food/Agriculture, suggesting personal enthusiasm for artisanal and natural food production.

Key themes

Biotech Investing

Active investment in pharmaceutical and biotech firms, focusing on oncology and drug delivery innovations.

  • Significant shareholder in Nuvectis Pharma with 9.95% ownership [4]

  • Form 4 filing and $247k stock purchase [1][8]

  • Insider benefits from market cap rises [6][7]

Hedge Fund and Corporate Ties

Involvement in hedge funds and biotech companies like Flamel Technologies/Avadel.

  • Well-known in hedge fund world at Flamel Technologies [5]

  • Email contacts at Avadel [2]

Natural Wine Support

Early backer of natural wine culture, emphasizing full name usage in publications.

  • Early supporter noted in book errata [3]

Sources (8)

Every entry that fed the multi-agent compile above. Inline citation markers in the wiki text (like [1], [2]) are not yet individually linked to specific sources — this is the full set of sources the compile considered.

  1. r/NuvectisPhama - Redditarticle · 2026-04-14
  2. Charles Marlio Email & Phone Number | Flamel Technologies ...article · 2026-04-14
  3. Errata in THE WORLD OF NATURAL WINE - by Aaron Ayscougharticle · 2026-04-14
  4. Nuvectis Pharma - Futubull - 富途资讯article · 2026-04-14
  5. Biography Of Charles Mosseri Marlio Of Flamel technologies - Spikingarticle · 2026-04-14
  6. Nuvectis Pharma, Inc.'s (NASDAQ:NVCT) market cap rose US$18m last week; individual investors who hold 44% profited and so did insiders - simplywall.stnews_article · 2026-04-14
  7. A US$22m Market Cap Boost Pleasing ToNuvectis Pharma Insiders - simplywall.stnews_article · 2026-04-14
  8. Nuvectis pharma investor Charles Mosseri Marlio buys $247k in stock By Investing.com - Investing.comnews_article · 2026-04-14